|
| Reference no. | Title | Research objective | Application limitations of 18F-FDG PET/CT |
|
| [36] | 18F-FLT-PET/CT adds value to 18F-FDG-PET/CT for diagnosing relapse after definitive radiotherapy in patients with lung cancer. Results of a prospective clinical trial | It investigated the value of 18F-FLT-PET/CT and 18F-FDG-PET/CT in diagnosing recurrence of radiation cancer | The specificity of 18F-FLT-PET/CT and 18F-FDG-PET/CT in the diagnosis of cancer patients after recurrence was reduced, and the efficiency of single application was significantly lower than the effect of the combination of the two |
|
| [37] | Prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography after autologous hematopoietic stem cell transplantation in lymphoma using deauville scores | It aimed to evaluate 2-deoxy-2-[18F]fluoro-D-glucose ([18F]F-FDG) positron emission tomography (PET)/computed tomography (CT) in lymphoma autologous stem cell transplantation (ASCT) | Applicable time was limited. |
|
| [38] | Prognostic value of 18F-FDG PET/CT in T-Lymphoblastic lymphoma before and after hematopoietic stem cell transplantation | It was to evaluate the prognostic value of 18F-FDG PET/CT in patients with relapsed or refractory t-lymphoid transplantation (T-LBL) undergoing hematopoietic stem cell transplantation (HSCT). | Pre-PET failed to predict PFS and OS in T-LBL patients treated with HSCT. |
|
| [41] | Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET/CT according to DSUVmax, deauville 5-point scale and IHP criteria | It compared different interpretation methods of 18F-FDG PET/CT in predicting disease prognosis to determine the best method in this regard | Effective evaluation indicators for predicting disease prognosis were different before and after treatment, and further research was needed to find the best indicator |
|
| [42] | Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with posttransplant lymphoproliferative disorder: a systematic review and meta-analysis | It aimed to evaluate the clinical performance of advanced imaging modalities in the diagnosis and treatment response assessment of PTLD patients after solid organ and hematopoietic stem cell transplantation | FDG-PET(/CT) was well-applied for detection, staging, and treatment evaluation, but has methodological flaws, false-negatives due to physiologic high background activity and early PTLD lesions, and false-positives due to inflammatory conditions |
|
| [43] | Diagnostic performances of F-18 FDG PET or PET/CT for detection of posttransplant lymphoproliferative disorder: a systematic review and meta-analysis | It aimed to investigate the diagnostic performance of F-18 FDG PET or PET or PET/CT for the detection of posttransplant lymphoproliferative disease (PTLD) | The scope of the study was limited and further large multicenter studies were needed to confirm |
|
